美国FDA批准在家送的tDCS用于治疗抑郁症
Marom Bikson1, Andre Brunoni2, Mark S George3
1Department of Biomedical Engineering, The City College of New York, New York (NY) USA.
Brain stimulation
|December 31, 2025
概括
美国食品和药物管理局批准了一种新型家庭使用的神经调制装置,用于治疗严重抑郁症 (MDD). 这种横直流刺激 (tDCS) 装置标志着非药物抑郁症治疗的重大进步.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 医疗器械 医疗器械
背景情况:
- 重度抑郁症 (MDD) 是一种普遍且使人虚弱的心理健康状况.
- 非药物治疗越来越多地被寻求用于抑郁症管理.
- 基于家庭的神经调节提供了增加可访问性和患者便利性的潜力.
研究的目的:
- 报告FDA对一种用于治疗MDD的新型家庭使用神经调节装置的市场前批准 (PMA).
- 突出这一监管里程碑对非药物抑郁症治疗的意义.
主要方法:
- 流动神经科学跨头直流刺激 (tDCS) 设备获得了FDA的批准.
- 获得批准用于治疗成年人 (18岁以上) 中度至重度MDD.
- 该设备适用于非治疗耐药患者的单一治疗或辅助治疗.
主要成果:
- 首个FDA PMA用于家庭使用的非侵入性脑刺激装置用于抑郁症.
- 该设备已被批准用于特定患者群体和治疗场景.
- 这项批准意味着监管方面取得了重大进展.
结论:
- 美国食品和药物管理局对Flow Neuroscience tDCS设备的批准代表了抑郁症治疗的里程碑式成就.
- 预计这一里程碑将加速家庭神经调节技术的开发和采用.
- 它为精神卫生保健中的非药物干预开辟了新的途径.
相关概念视频
Antidepressant Drugs: Overview
2.1K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
2.1K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
2.4K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.4K
Antidepressant Drugs: MAOIs and Other Agents
1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Therapeutic Drug Monitoring: Affecting Factors
438
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
438
Transdermal Drug Delivery Systems
243
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
243
Electroconvulsive Therapy
2.6K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.6K
